Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis Patients
Condition:   Rheumatoid Arthritis Interventions:   Drug: Rebamipide;   Drug: Nanoparticulated Rebamipide;   Drug: Clobetasol Propionate Sponsor:   Cairo University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2020 Category: Research Source Type: clinical trials

Efficacy of Topical Treatment With Clobetasol in Symptomatic Oral Lichen Planus.
Condition:   Oral Lichen Planus Interventions:   Drug: Clobetasol Propionate;   Drug: Placebo/active;   Drug: Placebo/placebo Sponsors:   Malmö University;   Skane University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2020 Category: Research Source Type: clinical trials

Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2)
Condition:   Cataract Interventions:   Drug: Clobetasol Propionate;   Drug: Vehicle Sponsor:   Salvat Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2020 Category: Research Source Type: clinical trials

Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1)
Condition:   Cataract Interventions:   Drug: Clobetasol propionate;   Drug: Vehicle Sponsor:   Salvat Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2020 Category: Research Source Type: clinical trials

Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis
Condition:   Atopic Dermatitis Intervention:   Drug: Clobetasol propionate 0.05% Topical Oil Sponsor:   Hill Dermaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials

Intradermal LPS and Antibiotics
Condition:   Inflammation; Skin Interventions:   Drug: Erythromycin 4% topical gel formulation:;   Drug: Clindamycin 1% lotion formulation:;   Drug: Prednisolone tablet (0.5mg/kg; parallel comparison):;   Drug: Clobetasol propionate 0.05% topical formulation (crossover comparison):;   Other: Lipopolysaccharide Sponsors:   Centre for Human Drug Research, Netherlands;   Cutanea Life Sciences, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2018 Category: Research Source Type: clinical trials